Category: Journal Club

December 2022 Written by:  Jordan Deaner, MD Mid Atlantic Retina / Wills Eye Hospital Philadelphia, PA Rush RB, Velazquez JC, Rosales CR, Rush SW. Gas Tamponade for the Prevention of Postoperative Vitreous Hemorrhaging After Diabetic Vitrectomy: A Randomized Clinical Trial. Am J Ophthalmol. 2022;242:173-180. doi:10.1016/j.ajo.2022.06.015 Disclosures: EyePoint – Consultant, Alimera – Consultant Vitreous hemorrhage (VH) […]

December 2022 Written by:  Jordan Deaner, MD Mid Atlantic Retina / Wills Eye Hospital Philadelphia, PA Holz FG, Oleksy P, Ricci F, et al. Efficacy and safety of biosimilar FYB201 compared with ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2022;129(1):54-63.   Recently the United States Food and Drug Administration (USFDA) approved the first interchangeable biosimilar for use […]

November 2022 Written by:  Katherine E. Talcott, MD Cole Eye Institute / Cleveland Clinic Hirabayashi K, Yu HJ, Wakatsuki Y, Marion KM, Wykoff CC, Sadda SR. OCT risk factors for development of atrophy in eyes with intermediate age-related macular degeneration. Ophthalmol Retina. 2022;6;S2468-6530(22)00486-9. doi 10.1016/j.oret.2022.09.007. Online ahead of print. While treatments for atrophic age-related macular […]

August 2022 Written by:  Nika Bagheri, MD California Retina Consultants Santa Barbara, CA Kanai M., Sakimoto S., Takahashi S., Nishida K., Maruyama K., Sato S., Sakaguchi H. & Nishida K., Embedding Technique versus Conventional Internal Limiting Membrane Peeling for Lamellar Macular Hole with Epiretinal Proliferation, Ophthalmology Retina (2022), doi: https:// doi.org/10.1016/j.oret.2022.07.009.  The purpose of this […]

June 2022 Written by:  Wenlan Zhang, MD Retina Northwest Portland, OR Patel, N. Yannuzzi, N. Lin, J. Smiddy, W. A Cost-Effectiveness Analysis of Intravitreal Aflibercept for the Prevention of Progressive Diabetic Retinopathy. Ophthalmol Retina. 2022;6:213-218. This was a cost-effectiveness analysis based on published data from two recent randomized control trials studying the early treatment of […]

May 2022 Written by: Phillip Storey, MD Austin Retina Associates Austin, TX Friling E, Johansson B, Londsteom M, et al. Postoperative endophthalmitis in immediate sequential bilateral cataract surgery: a nationwide registry study.Ophthalmology. 2022;129(1):26-34. Lacy M, Kung T, Owens J, et al. Endophthalmitis rate in immediately sequential versus delayed sequential bilateral cataract surgery within the IRIS registry […]

May 2022 Written by: Edward Wood, MD Austin Retina Associates Austin, TX Wykoff, C. C., F. Abreu, A. P. Adamis, and K. Basu. 2022. “Efficacy, Durability, and Safety of Intravitreal Faricimab with Extended Dosing up to Every 16 Weeks in Patients with Diabetic Macular Oedema (YOSEMITE and RHINE): two randomized, double-masked, phase 3 trials. The Lancet. […]

May 2022 Written by: Daniel Su, MD Retina-Vitreous Associates Medical Group Los Angeles, CA Hwang ES, Kraker JA, Griffin KJ, Sebag J, Weinberg DV, Kim JE. Accuracy of Spectral-Domain OCT of the Macula for Detection of Complete Posterior Vitreous Detachment. Ophthalmol Retina. 2020 Feb;4(2):148-153.  Posterior vitreous detachment (PVD) is the age-related separation of vitreous from […]